New Study Confirms Vapotherm’s Unicorn™ Cannula Provides Comparable Efficacy at Lower Flow Rates
Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of Single-Prong Cannula Design with High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates, in Critical Care Explorations. The study demonstrates that the ProSoft® Unicorn™ Cannula, a single-prong high velocity therapy cannula, provides comparable relief of dyspnea at a significantly lower flow rates compared to traditional dual-prong cannulas.
